Most impactful predictors for hyperoxaemia in exacerbation of chronic obstructive pulmonary disease managed by Emergency Medical Services and Emergency Department
Introduction Hyperoxemia in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) leads to adverse outcomes. It remains prevalent in the pre‐hospital Emergency Medical Services (EMS) and Emergency Department (ED). Objective To determine the key predictors for hyperoxemia in AECOPD in...
Gespeichert in:
Veröffentlicht in: | The clinical respiratory journal 2019-04, Vol.13 (4), p.256-266 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction
Hyperoxemia in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) leads to adverse outcomes. It remains prevalent in the pre‐hospital Emergency Medical Services (EMS) and Emergency Department (ED).
Objective
To determine the key predictors for hyperoxemia in AECOPD in EMS and ED.
Methods
This was a prospective observational study of AECOPD patients in EMS and two EDs. Hyperoxemia was defined as PaO2 > 65 mm Hg (corresponds to SpO2 > 92%). We determined apriori candidate factors in Patient, Organization and Staff domains. Primary outcomes were the key predictors for hyperoxemia. Secondary outcomes were in‐hospital mortality and mechanical ventilation rates in hyperoxemic versus non‐hyperoxemic groups. We generated a logistic regression model for each domain. We reported the adjusted odds ratios (AORs), 95% CIs and p values. We selected the output factors using AOR ≥2.0 and ≥2.5 for modifiable and non‐modifiable factors, respectively. These selected factors were fed into a final model with eventual factors selected based on: threshold AORs as stated above and/or 95% CIs including these AORs.
Results
Three hundred and twenty‐six patients were analysed; 60.7% had hyperoxemia. We found three eventual modifiable factors; first, ED SpO2 > 95% [AOR 2.62 (95% CIs: 1.61‐4.33); P |
---|---|
ISSN: | 1752-6981 1752-699X |
DOI: | 10.1111/crj.13007 |